Mark G Wise

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Topics

Multidrug Resistant

Genetic Diversity

Top Venues

JAC-antimicrobial resistance

Antimicrobial agents and chemotherapy

The Journal of antimicrobial chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

James A Karlowsky, Mark G Wise, Meredith A Hackel, David A Six, Tsuyoshi Uehara, Denis M Daigle, Daniel C Pevear, Greg Moeck, Daniel F Sahm
Cefepime-taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018-22. The Journal of antimicrobial chemotherapy (2024)
Mark G Wise, C Andrew DeRyke, Irina Alekseeva, Fakhar Siddiqui, Katherine Young, Mary R Motyl, Daniel F Sahm
Susceptibility of Gram-negative pathogens collected in Israel to ceftolozane/tazobactam, imipenem/relebactam and comparators: SMART 2018-22. JAC-antimicrobial resistance 6 (5) (2024)
James A Karlowsky, Mark G Wise, Wei-Ting Chen, Fakhar Siddiqui, Katherine Young, Mary R Motyl, Daniel F Sahm
Susceptibility of Gram-negative isolates collected in South Korea to imipenem/relebactam and comparator agents-SMART 2018-21. JAC-antimicrobial resistance 6 (1) (2023)
James A Karlowsky, Mark G Wise, Wei-Ting Chen, Fakhar Siddiqui, Katherine Young, Mary R Motyl, Daniel F Sahm
Susceptibility of Gram-negative isolates collected in South Korea to imipenem/relebactam and comparator agents-SMART 2018-21. JAC-antimicrobial resistance 6 (1) (2023)
Mark G Wise, James A Karlowsky, Naglaa Mohamed, Shweta Kamat, Daniel F Sahm
In vitro activity of aztreonam-avibactam against Enterobacterales isolates collected in Latin America, Africa/Middle East, Asia, and Eurasia for the ATLAS Global Surveillance Program in 2019-2021. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2023)
James A Karlowsky, Mark G Wise, Meredith A Hackel, Daniel C Pevear, Greg Moeck, Daniel F Sahm
Ceftibuten-Ledaborbactam Activity against Multidrug-Resistant and Extended-Spectrum-β-Lactamase-Positive Clinical Isolates of Enterobacterales from a 2018-2020 Global Surveillance Collection. Antimicrobial agents and chemotherapy 66 (11) (2022)
Mark G Wise, Mark A Estabrook, Daniel F Sahm, Gregory G Stone, Krystyna M Kazmierczak
Prevalence of mcr-type genes among colistin-resistant Enterobacteriaceae collected in 2014-2016 as part of the INFORM global surveillance program. PloS one 13 (4) (2018)